Megestrol Acetate Therapy in Geriatric Patients: Case Reviews and Associated Deep Vein Thrombosis

Consultant Pharmacist

Volumn 18, Issue 9, 2003, Pages 764-773

  Marshall, Leisa L ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

Deep vein thrombosis; Megestrol acetate; Thromboembolic events; Unplanned weight loss

Indexed keywords

MEGESTROL ACETATE;

AGED; ANOREXIA; BREAST CARCINOMA; CACHEXIA; CANCER PALLIATIVE THERAPY; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DIARRHEA; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE COURSE; DRUG APPROVAL; DRUG WITHDRAWAL; ENDOMETRIUM CARCINOMA; FEMALE; GERIATRIC CARE; HUMAN; IMPOTENCE; LUNG EMBOLISM; MEDLINE; NURSING HOME; PROSPECTIVE STUDY; RASH; RETROSPECTIVE STUDY; REVIEW; RISK BENEFIT ANALYSIS; TABLET FORMULATION; VULNERABLE POPULATION; WEIGHT REDUCTION;

EID: 0842300584     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Huffman GB. Evaluating and treating unintentional weight loss in the elderly. Am Fam Physician 2002;65:640-50.
2. Miller LJ, Kwan RC. Pharmacologic treatment of undernutrition in the geriatric patient. Consult Pharm 2002;17:739-47.
3. Demling RH, Walaszek P, Collins N. Unplanned weight loss: causes and consequences in the elderly long-term care facility resident. Consult Pharm 2002;17(suppl A):3-10.
4. Wedick NM, Barrett-Conner E, Knoke JD et al. The relationship between weight loss and all-cause mortality in older men and women with and without diabetes mellitus: the Rancho Bernardo study. J Am Geriatr Soc 2002;50:1810-5.
5. Wallace JI, Schwartz RS, Croix AL. Unplanned weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc 1995;43:329-37.
6. Walaszek P, Collins N, Demling RH. Unplanned weight loss: treatment issues in long-term care. Consult Pharm 2002;17(suppl A):11-21.
7. Morley JE, Silver AJ. Nutritional issues in nursing home care. Ann Intern Med 1995;123:850-9.
8. Thomas DR, Ashmen W, Morley, JE et al. Nutritional management strategies in long-term care: development of a clinical guideline. J Gerontol A Med Sci 2000;55A:M725-34.
9. Demling RH, DeSanti L. The stress response to injury and infection: role of nutritional support. Wounds 2000;12:3-14.
10. Morley JE, Thomas DR, Wilson M-MG. Appetite and orexigenic drugs. Ann Long-Term Care 2001;9(suppl):1-12.
11. Singh MAF, Bernstein MA, Ryan AD. The effect of oral nutritional supplements on habitual dietary quality and quantity in frail elders. J Nutr Health Aging 2000;4:5-12.
12. Kastrup EK, Novak KK, Burnham TH. Drug Facts and Comparisons. St. Louis: Facts and Comparisons; 2003.
13. Demling RH, DeSanti L. The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent. Burns 2001;17:46-51.
14. Volicer L, Stelly M, Morris J. Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease. Intern J of Geriatr Psych 1997;12:913-9.
15. Bristol-Myers Squibb. Megace Oral Suspension, package insert 2002; revised July 2002.
16. VonRoenn J, Armstrong D, Kotler D et al. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 1994;121:393-9.
17. Koller E, Gibert C, Green L et al. Thrombotic events associated with megestrol acetate in patients with AIDS cachexia. Nutrition 1998;15:294-8.
18. Weisberg J, Wagner J, Olson J, Streit B. Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. Chest 2002;121:1070-8.
19. Bristol Myers Squibb Megace tablets package insert 2002; revised July 2002.
20. Farrar DJ. Megestrol acetate: promises and pitfalls. AIDS Pat Care STDs 1999;13:149-52.
21. Feliu J, Gonzalez-Baron M, Berrocal A et al. Usefulness of megestrol acetate in cancer cachexia and anorexia. Am J Clin Oncol 1992;15:436-40.
22. Loprinzi C, Kugler J, Sloan J et al. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 1999;17:3299-306.
23. Yeh S-S, Wu S-Y, Lee T-P et al. Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study. J Am Geriatr Soc 2000;48:485-92.
24. Castle S, Nguyen C, Joaquin A et al. Megestrol acetate suspension therapy in the treatment of geriatric anorexia/cachexia in nursing home patients. J Am Geriatr Soc 1995;43:835-6.
25. Yeh S, Wu S, Levine D et al. The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients. J Gerontol A Biol Sci Med Sci 2001;56:M48-M54.
26. Matthvs P, Billiau A. Cytokines and cachexia nutrition. Nutrition 1997;13:763-770.
27. Yeh S, Schuster MW. Geriatric cachexia: the role of cytokines. Am J Clin Nutr 1999;70:183-7.
28. Raney MS, Anding R, Fay V et al. A pilot study to assess the use of megestrol acetate to promote weight gain in frail elderly persons residing in long-term care. J Am Med Dir Assoc 2000;1:154-8.
29. Bolen JC, Andersen RE, Bennett RG. Deep vein thrombosis as a complication of megestrol acetate therapy among nursing home residents. J Am Med Dir Assoc 2000;48:248-52.
30. Cicero LA, Rosenberg JM, Miyashiro A et al. Megestrol acetate suspension for the treatment of unplanned weight loss in elderly nursing home residents: a retrospective chart review. Consult Pharm 2000;15:811-4.
31. Dickerson LM, Jones KW. Retrospective review and intervention in the use of megestrol acetate in residents of skilled nursing facilities in South Carolina. Consul Pharm 2002;17:1040-44.